Видео с ютуба Foundation For Angelman Syndrome Therapeutics

MVX 220: A Gene Replacement Therapy for Angelman Syndrome

MVX 220: A Gene Replacement Therapy for Angelman Syndrome
Grand Prize Winner Introduction: Foundation for Angelman Syndrome Therapeutics (FAST)

Grand Prize Winner Introduction: Foundation for Angelman Syndrome Therapeutics (FAST)
Allyson Berent (Part 2) | 2022 FAST Summit on Angelman Syndrome

Allyson Berent (Part 2) | 2022 FAST Summit on Angelman Syndrome
2019 FAST Summit on Angelman Syndrome - Genetics and Therapeutic Overview, Allyson Berent, CSO FAST

2019 FAST Summit on Angelman Syndrome - Genetics and Therapeutic Overview, Allyson Berent, CSO FAST
Загадка синдрома Ангельмана

Загадка синдрома Ангельмана
Overview of the Therapeutic Landscape for Angelman Syndrome

Overview of the Therapeutic Landscape for Angelman Syndrome
Open Book with FAST (Foundation for Angelman Syndrome Therapeutics)

Open Book with FAST (Foundation for Angelman Syndrome Therapeutics)
Therapeutic Strategies for the Treatment of Angelman syndrome Dr Allyson Berent 2020 FAST Science

Therapeutic Strategies for the Treatment of Angelman syndrome Dr Allyson Berent 2020 FAST Science
2018 FAST Science Summit - Gene Therapy for Angelman Syndrome

2018 FAST Science Summit - Gene Therapy for Angelman Syndrome
Angelman Syndrome - Gene therapy

Angelman Syndrome - Gene therapy
Jacob Family Pledges $250,000 to the Foundation for Angelman Syndrome Therapeutics

Jacob Family Pledges $250,000 to the Foundation for Angelman Syndrome Therapeutics
August 23rd Webcast with FAST, Ovid, and Angelman Syndrome Foundation

August 23rd Webcast with FAST, Ovid, and Angelman Syndrome Foundation
2019 FAST Summit on Angelman Syndrome: Functional Behavioral Assessment in AS by Dr. Barbara Cannon

2019 FAST Summit on Angelman Syndrome: Functional Behavioral Assessment in AS by Dr. Barbara Cannon
Heartbreak to Hope: A Mother’s Mission to Cure Angelman Syndrome | Dr Allyson Berent, CSO of FAST

Heartbreak to Hope: A Mother’s Mission to Cure Angelman Syndrome | Dr Allyson Berent, CSO of FAST
Angelman Syndrome Phase 3 Clinical Trial Update

Angelman Syndrome Phase 3 Clinical Trial Update
Angelman Syndrome Genetics 101 and 102

Angelman Syndrome Genetics 101 and 102
Developing therapies for Angelman syndrome

Developing therapies for Angelman syndrome
2019 FAST Summit on Angelman Syndrome - ASO Therapy for AS - Dr. Frank Bennett, Ionis Pharmaceutical

2019 FAST Summit on Angelman Syndrome - ASO Therapy for AS - Dr. Frank Bennett, Ionis Pharmaceutical
Research Updates from the 2019 Angelman Syndrome Foundation Conference

Research Updates from the 2019 Angelman Syndrome Foundation Conference